Register for OBR daily


IMS_White_300x250

To find out more about a company click on the company name to see a brief profile.

OBR Finance Top 5 Winners

IMNP $3.28 0.3300 +11.19%
RNN $0.74 0.0300 +4.23%
IDRA $2.45 0.0700 +2.94%
BCRX $11.70 0.3300 +2.90%
MYGN $37.60 0.9200 +2.51%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

OBR Finance Top 5 Losers

ONTY $1.77 -0.1300 -6.84%
GALT $4.76 -0.3300 -6.48%
DNDN $1.03 -0.0700 -6.36%
NWBO $4.78 -0.3100 -6.09%
Kite $33.69 -2.0600 -5.76%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

Archived News Headlines

We have been archiving all OBR daily news stories since March 2008. Use the box below to search our archives for specific articles and content.

Please note: we do not "host" news articles on our website. When a media source removes an article from their website the link becomes inactive, and you will only be able to see the date, title, first sentence and media source that published the article.

<< First | < Prev | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | Next > | Last >>

Osteoporosis Treatment May Also Benefit Breast Cancer Patients

(McGill Reporter [Montreal, Canada]) Oct 2, 2014 - A new study, published in this month’s issue of the Journal of the National Cancer Institute (JNCI), is among the first to link bisphosphonate (a common osteoporosis medication) use with improved survival in women with breast cancer.
read article 



Researchers Discover Gene That Can Predict Aggressive Prostate Cancer at Diagnosis

(MD Anderson) Oct 2, 2014 - Researchers at The University of Texas MD Anderson Cancer Center have identified a biomarker living next door to the KLK3 gene that can predict which GS7 prostate cancer patients will have a more aggressive form of cancer.
read press release 



NICE 'No' for Roche's Gazyvaro in CLL

(PharmaTimes [UK]) Oct 3, 2014 - Cost regulators are minded to refuse patients with untreated chronic lymphocytic leukaemia access to Roche’s Gazyvaro on the National Health Service.
read article 



FDA Advisory Panel Calls for More Data on HIFU Treatment

(Medscape Medical News) Oct 2, 2014 - A US Food and Drug Administration (FDA) advisory committee voted October 1 not to recommend approval, at least for now, of a high-intensity focused ultrasound (HIFU) device to treat some patients with recurrent prostate cancer.
read article (free registration required) 



UK Cost Agency NICE Rejects Another Roche Cancer Drug

(Reuters) Oct 2, 2014 - Another new cancer drug from Roche , this time for treating leukaemia, has been rejected by Britain's healthcare cost-effectiveness agency NICE on the grounds that data about its value is uncertain.
read article 



4 US Deaths Linked to Enterovirus D68 Respiratory Illness

(FoxNews.com/Associated Press) Oct 1, 2014 - Officials are looking into the role a severe respiratory virus spreading across the country could have played in the deaths of four people infected with the disease.
read article 



Eli Lilly to Stop Development of Tabalumab for Lupus

(Wall Street Journal) Oct 2, 2014 - Eli Lilly and Co. said Thursday it will stop development of its tabalumab treatment for lupus, and won't move forward with submissions of the treatment to global regulators.
read article (paid subscription required) 



U.S. Will Increase Production of the Ebola Drug ZMapp, but May Not Meet Demand

(New York Times) Oct 1, 2014 - Federal officials are planning to sharply increase production of ZMapp, which is viewed by many experts as the most promising experimental drug for treating people infected with Ebola in West Africa.
read article 



FDA Warns of Risk to Patient Data

(The Hill) Oct 1, 2014 - The Food and Drug Administration (FDA) is issuing new cybersecurity recommendations to help healthcare companies protect patient information that is stored on medical devices.
read article 



Nine-valent HPV Vaccine May Prevent Nearly 90 Percent of Cervical Cancers

(AACR) Oct 1, 2014 - Because nine human papillomavirus (HPV) subtypes were found to cause the majority of cervical precancers, a nine-valent HPV vaccine currently being investigated may be able to prevent more cervical cancers than current vaccines, according to research published in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research.
read press release 



Gov't Website for Doc Payments Not Up to Snuff

(ABC News/Associated Press) Oct 2, 2014 - Another year, another headache for the Obama administration over a health care website.
read article 



Dr. Anjan J. Patel Joins Florida Cancer Specialists & Research Institute

(FCS) Oct 1, 2014 - Florida Cancer Specialists & Research Institute (FCS) is pleased to announce that Anjan J. Patel, MD, has joined the practice and will be seeing patients at the Sarasota Downtown office beginning October 1, 2014.
read press release 



Drs. Servillano Dela Cruz, Jr. and William Harrer Join Florida Cancer Specialists & Research Institute

(FCS) Oct 1, 2014 - Florida Cancer Specialists & Research Institute (FCS) is pleased to announce that Dr. Servillano E. Dela Cruz Jr. and Dr. William Harrer, formerly of Citrus Hematology & Oncology, have joined the statewide practice.
read press release 



Drs. Noor Merchant and Raul Storey-Rojas Join Florida Cancer Specialists & Research Institute

(FCS) Oct 1, 2014 - Florida Cancer Specialists & Research Institute (FCS) is pleased to announce that Noor Merchant, MD and Raul Storey-Rojas, MD have joined the statewide practice.
read press release 



For This October, A New Kind of Breast Cancer Awareness

(Forbes) Oct 1, 2014 - Patients need support, and researchers need funds.
read article 



GE Healthcare Study: Most People Unaware that Women with High Breast Density are 4 to 5 Times More Likely to Develop Breast Cancer

(GE) Oct 2, 2014 - Three out of four people are not aware that dense breast tissue increases a woman’s risk of developing breast cancer, according to a new global study from GE Healthcare exploring perspectives on breast cancer with an emphasis on understanding awareness around dense breast tissue and the most common symptoms of breast cancer.
read corporate press release 



HHS Releases 13th Report on Carcinogens

(NIH) Oct 2, 2014 - Four substances have been added in the U.S. Department of Health and Human Services 13th Report on Carcinogens, a science-based document that identifies chemical, biological, and physical agents that are considered cancer hazards for people living in the United States. The new report includes 243 listings.
read press release 



Ready for Some Good News?

(ACCCBuzz) Oct 1, 2014 - Richard Rossi, the keynote speaker at ACCC’s 31st National Oncology Conference in San Diego, Calif., October 8-10, 2014, will introduce meeting attendees to some of the country’s most gifted teenage researchers who are already changing the future of cancer care.
read article 



ASCO Comments on CMMI Proposed Cancer Care Payment Reform Model

(ASCO in Action) Oct 1, 2014 - ASCO recently submitted comments to the Centers for Medicare and Medicaid Innovation (CMMI)—a component of the Centers for Medicare & Medicaid Services (CMS)—regarding the center’s proposed cancer care payment and service delivery model, Preliminary Design for an Oncology Focused Model (OCM).
read article 



NCI Invites Clinicians to Identify Exceptional Responders

(ASCO in Action) Oct 1, 2014 - The National Cancer Institute announced the launch of the Exceptional Responders Initiative, a study that will investigate the molecular factors associated with exceptional responses to treatment therapies in cancer patients.
read article 



NCI Launches RAS Program Website for Researchers

(ASCO in Action) Oct 1, 2014 - The National Cancer Institute's RAS Program has launched a new website, a tool for researchers working to better understand the role of RAS mutations in cancer.
read article 



Multiple Myeloma Research Consortium (MMRC) Hits all Time Record-Opens Six New Clinical Trials in 2014

(Yahoo! Finance) Oct 1, 2014 - Six new trials represent some of the most promising and brand new treatments in development today.
read article 



Study Examines Medical Professional Liability Claims Related to Esophageal Cancer Screening

(U-M Health System) Sept 30, 2014 - An analysis of liability claims related to esophageal cancer screening finds that the risk of claims arising from failing to screen as well as complications of the procedure used to screen for the cancer are similarly low, according to a study in the Oct. 1 issue of JAMA.
read press release 



Proton Center Closure Doesn't Slow New Construction

(NPR Shots blog/Kaiser Health News) Oct 1, 2014 - A proton beam therapy center in Indiana is closing, and insurers are reluctant to cover the treatment for common cancers. But plans for three new proton therapy centers for the D.C. area are still on.
read article 



Review Identifies Factors Associated with Childhood Brain Tumors

(WUSTL) Oct 1, 2014 - Older parents, birth defects, maternal nutrition and childhood exposure to CT scans and pesticides are increasingly being associated with brain tumors in children, according to new research from the Brown School at Washington University in St. Louis.
read press release